FDA grants orphan drug status to ASLAN’s treatment for AML

World |  News | 0 Comment | 20 Aug, 2018

Singapore - ASLAN Pharmaceuticals, a clinical-stage biopharmaceutical company targeting cancers that are both highly prevalent in Asia and orphan indications in the United States and Europe...Read more

Tolero Pharmaceuticals collaborates with AbbVie for AML trial

World |  News | 0 Comment | 20 Aug, 2018

Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has entered into a clinical research collab...Read more

Verana Health Announces $30M Series C Financing

World |  News | 0 Comment | 20 Aug, 2018

Verana Health, the developer of a cutting-edge platform for life science innovation that utilizes regulatory-grade specialty data sets, has announced a $30 million Series C financing led by...Read more

FDA approves first generic version of EpiPen

World |  News | 0 Comment | 17 Aug, 2018

The U.S. Food and Drug Administration has approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including...Read more

Scientists develop platform to kill cancer cells

World |  News | 0 Comment | 17 Aug, 2018

An interdisciplinary group of scientists from NUST MISIS, Lomonosov Moscow State University, Pirogov Russian National Research Medical University (RNRMU), and the University of Duisburg-Ess...Read more

Dr Sundar receives an honor of first female President of BGCS

World |  News | 0 Comment | 16 Aug, 2018

University of Birmingham women’s cancer expert Dr Sudha Sundar has been chosen as the President-Elect of the British Gynaecological Cancer Society (BGCS), the first female gynaecologi...Read more

rfxcel enhances Pharmaceutical Track and Trace Solution for Russia

World |  News | 0 Comment | 16 Aug, 2018

rfxcel, the global leader in track and trace solutions, releases enhancements to its compliance solution for Russia and kicks off additional customer implementations in the Russian marketpl...Read more

Multi- institutional alliance to develop anti-aging drugs

World |  News | 0 Comment | 16 Aug, 2018

The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial intelligence (AI) to discover and develop novel anti-aging therapeutics ...Read more

Mylan brings first generic for Adcirca tablets

World |  News | 0 Comment | 14 Aug, 2018

Global pharmaceutical company Mylan N.V.  has announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first generic version of the reference listed drug, Eli Lilly and Comp...Read more

Orchard Therapeutics raises $150 M to improve Gene Therapy Pipeline

World |  News | 0 Comment | 13 Aug, 2018

Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, announced the completion of an...Read more

Researchers develop AI technique to treat cancer

World |  News | 0 Comment | 13 Aug, 2018

MIT researchers, including one of Indian-origin, have developed novel machine-learning techniques to improve the quality of life for patients by reducing toxic chemotherapy and radiotherapy...Read more

FDA approves Amicus' Galafold for Fabry disease

World |  News | 0 Comment | 13 Aug, 2018

Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indica...Read more

Artios Pharma announces $84 M Series B financing

World |  News | 0 Comment | 13 Aug, 2018

Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing innovative treatments for cancer has announced the completion of a $84 million (£65 million) Ser...Read more

Astellas acquires Quethera for up to £85M

World |  News | 0 Comment | 10 Aug, 2018

Singapore- Astellas Pharma and Quethera Limited announced that Astellas has acquired Quethera, a gene therapy company headquartered in the United Kingdom, that is focused on developing...Read more

OncoCyte appoints Albert P. Parker as COO

World |  News | 0 Comment | 10 Aug, 2018

Singapore- OncoCyte Corporation, a developer of novel, non-invasive liquid biopsy tests for the early detection of cancer, announced the appointment of Albert P. Parker, a seasoned ind...Read more

Genetic Technologies Formalises Strategic Alliance with Blockchain Global

World |  News | 0 Comment | 10 Aug, 2018

Genetic Technologies Limited, a diversified molecular diagnostics company embracing blockchain technologies across genomic testing platforms has announced that it has entered into a Framewo...Read more

NIH researchers discover highly infectious vehicle for transmission of viruses among humans

World |  News | 0 Comment | 10 Aug, 2018

Researchers have found that a group of viruses that cause severe stomach illness — including the one famous for widespread outbreaks on cruise ships — get transmitted to humans ...Read more

Yun Yen, MD, PhD and Winson (Sze Chun) Ho, MD Join Lixte Biotechnology’s Board of Directors

World |  News | 0 Comment | 09 Aug, 2018

Lixte Biotechnology Holdings, Inc. has announced the appointments of two new members to the Board of Directors of Lixte; Yun Yen, MD, Ph.D. and Winson (Sze Chun) Ho, MD. Yun Yen, M.D. Ph.D...Read more